351 related articles for article (PubMed ID: 24282529)
1. Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.
Zaharieva IT; Calissano M; Scoto M; Preston M; Cirak S; Feng L; Collins J; Kole R; Guglieri M; Straub V; Bushby K; Ferlini A; Morgan JE; Muntoni F
PLoS One; 2013; 8(11):e80263. PubMed ID: 24282529
[TBL] [Abstract][Full Text] [Related]
2. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as serum biomarkers in Becker muscular dystrophy.
Gagliardi D; Rizzuti M; Brusa R; Ripolone M; Zanotti S; Minuti E; Parente V; Dioni L; Cazzaniga S; Bettica P; Bresolin N; Comi GP; Corti S; Magri F; Velardo D
J Cell Mol Med; 2022 Sep; 26(17):4678-4685. PubMed ID: 35880500
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
[TBL] [Abstract][Full Text] [Related]
6. Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters.
Almeida-Becerril T; Rodríguez-Cruz M; Hernández-Cruz SY; Ruiz-Cruz ED; Mendoza CRS; Cárdenas-Conejo A; Escobar-Cedillo RE; Ávila-Moreno F; Aquino-Jarquin G
Acta Neurol Scand; 2022 Nov; 146(5):512-524. PubMed ID: 36000352
[TBL] [Abstract][Full Text] [Related]
7. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
[TBL] [Abstract][Full Text] [Related]
8. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
[TBL] [Abstract][Full Text] [Related]
9. Digital PCR quantification of miR-30c and miR-181a as serum biomarkers for Duchenne muscular dystrophy.
Llano-Diez M; Ortez CI; Gay JA; Álvarez-Cabado L; Jou C; Medina J; Nascimento A; Jimenez-Mallebrera C
Neuromuscul Disord; 2017 Jan; 27(1):15-23. PubMed ID: 27979502
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
[TBL] [Abstract][Full Text] [Related]
11. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.
Anthony K; Cirak S; Torelli S; Tasca G; Feng L; Arechavala-Gomeza V; Armaroli A; Guglieri M; Straathof CS; Verschuuren JJ; Aartsma-Rus A; Helderman-van den Enden P; Bushby K; Straub V; Sewry C; Ferlini A; Ricci E; Morgan JE; Muntoni F
Brain; 2011 Dec; 134(Pt 12):3547-59. PubMed ID: 22102647
[TBL] [Abstract][Full Text] [Related]
12. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
Hoffman EP
Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
[TBL] [Abstract][Full Text] [Related]
13. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.
Kinali M; Arechavala-Gomeza V; Feng L; Cirak S; Hunt D; Adkin C; Guglieri M; Ashton E; Abbs S; Nihoyannopoulos P; Garralda ME; Rutherford M; McCulley C; Popplewell L; Graham IR; Dickson G; Wood MJ; Wells DJ; Wilton SD; Kole R; Straub V; Bushby K; Sewry C; Morgan JE; Muntoni F
Lancet Neurol; 2009 Oct; 8(10):918-28. PubMed ID: 19713152
[TBL] [Abstract][Full Text] [Related]
14. miRNome profiling in Duchenne muscular dystrophy; identification of asymptomatic and manifesting female carriers.
Mousa NO; Sayed AA; Fahmy N; Elzayat MG; Bakry U; Abdellatif A; Zahra WK; Osman A
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34472584
[TBL] [Abstract][Full Text] [Related]
15. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
Maruyama R; Yokota T
Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217
[TBL] [Abstract][Full Text] [Related]
16. miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.
Hrach HC; Mangone M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546754
[TBL] [Abstract][Full Text] [Related]
17. Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen.
Anthony K; Feng L; Arechavala-Gomeza V; Guglieri M; Straub V; Bushby K; Cirak S; Morgan J; Muntoni F
Hum Gene Ther Methods; 2012 Oct; 23(5):336-45. PubMed ID: 23075107
[TBL] [Abstract][Full Text] [Related]
18. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover.
Roberts TC; Godfrey C; McClorey G; Vader P; Briggs D; Gardiner C; Aoki Y; Sargent I; Morgan JE; Wood MJ
Nucleic Acids Res; 2013 Nov; 41(20):9500-13. PubMed ID: 23945935
[TBL] [Abstract][Full Text] [Related]
19. Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.
Echigoya Y; Lim KRQ; Melo D; Bao B; Trieu N; Mizobe Y; Maruyama R; Mamchaoui K; Tanihata J; Aoki Y; Takeda S; Mouly V; Duddy W; Yokota T
Mol Ther; 2019 Nov; 27(11):2005-2017. PubMed ID: 31416775
[TBL] [Abstract][Full Text] [Related]
20. miRNAs as serum biomarkers for Duchenne muscular dystrophy.
Cacchiarelli D; Legnini I; Martone J; Cazzella V; D'Amico A; Bertini E; Bozzoni I
EMBO Mol Med; 2011 May; 3(5):258-65. PubMed ID: 21425469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
